ArticleClinical pharmacokinetics2026
Physiologically Based Pharmacokinetic Modeling of Elexacaftor-Tezacaftor-Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events.
Clotilde Vellat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.